US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA Part II

In an interview with Pharm Exec Associate Editor Don Tracy at the Financial Times U.S. Pharmaceutical and Biotechnology Summit, Tara Fakhoury, FDA Associate Director of Policy Analysis, discusses how FDA will limit the use of AI. We talk about whether we have plans and what the future holds. It might look the same for machine learning.